By MoH of Ukraine order No. 507 of 14.06.13, the package insert (hereinafter, the insert) was approved for the original (reference) medicinal product containing clobetasol, namely Dermovate™, ointment, cream, with amendments and additions to the following sections of the insert: "Contraindications," "Method of administration and doses," "Adverse reactions," "Overdose," "Use during pregnancy and breastfeeding," "Special warnings and precautions for use," "Interaction with other medicinal products and other forms of interaction."
List of medicinal products containing clobetasol as an active ingredient, authorized for medical use in Ukraine.
